Contattaci Contact Us

24 giugno 2022 - Giorno 1

  • Welcome and introduction

    Relatore Juan Verdejo

    Data Intervento 24/06/2022 - 08:45

  • Cardiovascular risk factors in Central and Latin America

    Relatore Miguel Camafort Babkowski

    Data Intervento 24/06/2022 - 09:00

  • What lipid test to order and how to interpret them?

    Relatore Francisco Padilla Padilla

    Data Intervento 24/06/2022 - 09:20

  • Diabetes Mellitus: The role of new drugs in Cardiovascular Prevention

    Relatore Josep Redon Mas

    Data Intervento 24/06/2022 - 09:40

  • Uric acid and Cardiovascular Risk

    Relatore Giuseppe Ambrosio

    Data Intervento 24/06/2022 - 10:00

  • The woman’s heart: what do we know?

    Relatore Lourdes Campos

    Data Intervento 24/06/2022 - 10:20

  • Q&A

    Relatore -

    Data Intervento 24/06/2022 - 10:40

  • Echocardiography, Strain imaging and myocardial work in hypertension

    Relatore Bijoy K. Khandheria

    Data Intervento 24/06/2022 - 11:20

  • β - blockers in the hypertension guidelines and CV continuum: where do we stand?

    Relatore Manolis S. Kallistratos

    Data Intervento 24/06/2022 - 11:40

  • Monotherapy vs Combination therapy. Which and for whom?

    Relatore Juan Guillermo Tamayo Maya

    Data Intervento 24/06/2022 - 12:00

  • A road map to future hypertension guidelines: are some changes needed?

    Relatore Guido Grassi

    Data Intervento 24/06/2022 - 12:20

  • Central Aortic Blood Pressure and Cardiovascular Risk

    Relatore Rubén Azañero

    Data Intervento 24/06/2022 - 12:40

  • Q&A

    Relatore -

    Data Intervento 24/06/2022 - 13:00

  • Imaging decision making in everyday clinical practice

    Relatore Adriana Puente

    Data Intervento 24/06/2022 - 14:30

  • Is it time to reconsider our beliefs towards PCI in the post-ISCHEMIA era?

    Relatore Peter Collins

    Data Intervento 24/06/2022 - 14:50

  • Microvascular angina: definition, diagnostic approach, and treatment

    Relatore Andreas Pittaras

    Data Intervento 24/06/2022 - 15:10

  • State of the art approach to managing angina and ischemia: tailoring treatment to the evidence

    Relatore Athanasios J. Manolis

    Data Intervento 24/06/2022 - 15:30

  • Q&A

    Relatore -

    Data Intervento 24/06/2022 - 15:50

  • Gold standard treatment for HFrEF

    Relatore Dragan Lovic

    Data Intervento 24/06/2022 - 16:15

  • Hypertension and stroke

    Relatore Antonio Coca Payeras

    Data Intervento 24/06/2022 - 16:35

  • Key messages from 2021 ESC/EACTS guidelines for the management of valvular heart disease

    Relatore Claudio Ferri

    Data Intervento 24/06/2022 - 16:55

  • 2021 AHA/ACC guidelines for the evaluation and diagnosis of chest pain

    Relatore J. L. Briseño De La Cruz

    Data Intervento 24/06/2022 - 17:15

  • Q&A

    Relatore -

    Data Intervento 24/06/2022 - 17:35

  • General Discussion

    Relatore -

    Data Intervento 24/06/2022 - 18:00

25 giugno 2022 - Giorno 2

  • Coagulation cascade: An overview and role of the New Oral Anticoagulants

    Relatore Felix A. Medina Palomino

    Data Intervento 25/06/2022 - 09:15

  • Thrombosis risk assessment and prevention

    Relatore J. L. Briseño De La Cruz

    Data Intervento 25/06/2022 - 09:35

  • Hypertension and atrial fibrillation

    Relatore Athanasios J. Manolis

    Data Intervento 25/06/2022 - 09:55

  • Diagnostic workup and treatment of thrombophilia

    Relatore Fernando Garcia-Frade Ruiz

    Data Intervento 25/06/2022 - 10:15

  • Q&A

    Relatore -

    Data Intervento 25/06/2022 - 10:35

  • Thromboprophylaxis in the Covid-19 and post Covid-19 era

    Relatore J. L. Briseño De La Cruz

    Data Intervento 25/06/2022 - 11:00

  • Adapting therapeutic strategies according to the frailty level

    Relatore Athanasios Benetos

    Data Intervento 25/06/2022 - 11:20

  • Thromboprophylaxis and obesity

    Relatore Fernando Garcia-Frade Ruiz

    Data Intervento 25/06/2022 - 12:00

  • Q&A

    Relatore -

    Data Intervento 25/06/2022 - 12:15

  • Dual antiplatelet and antithrombotic therapy. Which one and for whom?

    Relatore Juan Urquiaga

    Data Intervento 25/06/2022 - 13:30

  • An update of DOACs in atrial fibrillation and ablation

    Relatore Anastasios Lyras

    Data Intervento 25/06/2022 - 13:50

  • Combined versus Montherapy after DES. Guidelines say

    Relatore Anthony De Franco

    Data Intervento 25/06/2022 - 14:10

  • Anticoagulation in patients with heart failure: who, when, and why?

    Relatore Juan Verdejo

    Data Intervento 25/06/2022 - 14:30

  • Antidotes for reversal direct oral anticoagulants

    Relatore Fernando Garcia-Frade Ruiz

    Data Intervento 25/06/2022 - 14:50

  • Q&A

    Relatore -

    Data Intervento 25/06/2022 - 15:10

  • What’s new in antithrombotic treatment of VTE diasease: ACCP guidelines update 2021

    Relatore Luis Antonio Alcocer Diaz Barreiro

    Data Intervento 25/06/2022 - 15:35

  • Key messages from recent published guidelines on pulmonary embolism

    Relatore Jose Manuel Ceresetto

    Data Intervento 25/06/2022 - 15:55

  • Anticoagulation in Pregnancy

    Relatore Dora Ines Salazar Molina

    Data Intervento 25/06/2022 - 16:15

  • Q&A

    Relatore -

    Data Intervento 25/06/2022 - 16:30

  • Final Discussion and Future directions

    Relatore -

    Data Intervento 25/06/2022 - 16:45

VGFM DATA-LAYER

Area riservata

APP FONDAZIONE MENARINI



Pills of Art Menarini

“Menarini Pills of Art”
Il nuovo progetto multimediale di Menarini legato al mondo dell’arte



Nuovi Progetti: MINUTI DIGITALE



Minuti Menarini Online

Abbonati gratis alla rivista cartacea



Fondazione Internazionale Menarini



ISCRIVITI ALLA NEWSLETTER

Ricevi ogni mese le informazioni sulle attività della Fondazione Internazionale Menarini.

VGFM DATA-LAYER

Fondazione Internazionale Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484